ARCHIVES

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

February 28, 2003

Women’s Health Trial RFPs Issued; Three Clinical Centers Sought

April 12, 1991

More Patients Get Screened, Colorectal Death Rates Drop

July 29, 2011

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000

Hammer Signs $2.5 Mil. Check To NCI Fro Stop Cancer Campaign

February 2, 1990